1,012
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms

, Ph.D.ORCID Icon, , M.A.ORCID Icon & , Ph.D. C Psych
Pages 70-80 | Received 02 Nov 2020, Accepted 01 Mar 2021, Published online: 20 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mitch Earleywine, Fiona Low, Brianna R. Altman & Joseph De Leo. (2023) How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?. Journal of Psychoactive Drugs 55:1, pages 51-61.
Read now
Brianna R. Altman, Mitch Earleywine & Joseph De Leo. (2022) Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression. Journal of Psychoactive Drugs 54:5, pages 462-470.
Read now
Amanda Tamman, Amit Anand & Sanjay J. Mathew. (2022) A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression. Expert Opinion on Drug Safety 21:6, pages 745-759.
Read now

Articles from other publishers (1)

Mitch Earleywine, Maha N. Mian & Joseph A. De Leo. (2023) Expectancies for Subjective and Antidepressant Effects in Psilocybin Users. Journal of Humanistic Psychology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.